Regulatory Intelligence Pharm3r’s platform aggregates regulatory actions across FDA, Health Canada, recalls, inspections, and Form 483s, presenting a rich source for underwriters and pharma compliance teams to assess risk exposure and prioritize coverage or defense strategies.

Post-market Insight Extensive adverse event analytics using FAERS and MAUDE data with real-time disproportionality metrics enables insurers, manufacturers, and legal entities to benchmark product safety profiles and identify emerging risk signals for portfolio adjustments.

Supply Chain Visibility Mapping 93,000+ facilities with product-to-facility hierarchy supports supply chain risk monitoring and regulatory action tracking, offering a basis for insurer diversification, supplier due diligence, and business disruption planning.

Clinical Trial Intelligence Access to 454,000+ ClinicalTrials.gov trials with cross-referenced adverse events creates opportunities for risk scoring, product lifecycle planning, and competitive intelligence for life sciences clients engaging in trial strategy assessments.

Underwriter Portfolio Portfolio management and concentration risk visualization at the book level aligns well with life sciences underwriters seeking data-driven exposure insights, enabling tailored product offerings and targeted risk pricing.